For IC50 measurement using the FGFR inhibitors, cells were dissociated into single cells and seeded into a 384-well tissue culture plate, each well with 200 viable cells and 40μL of growth medium. After 24 hours, compounds were added to each well over a 15-point concentration range, along with DMSO controls, using a Tecan D300e digital drug dispenser. Cells were cultured for 5 days in the presence of compound before assessing viability by adding 15μL of Cell Titer-Glo (Promega) to each well, incubating for 20 minutes at room temperature on a shaker, and measuring luminescence using an Envision plate reader. Each condition was performed in 5 replicates, and each dose point was normalized to DMSO controls to estimate relative viability. At least 2 independent experiments were performed for each compound and cell line. IC50 values were determined by GraphPad Prism using a 4-parameter dose-response model. Crystal violet staining assays were done by seeding cells into 6-well plates one day before addition of drug. Cells were grown in the presence of drug for four days (CCLP-1 cells) or two weeks (ICC13–7 cells), then washed with PBS, fixed with cold methanol, stained with 0.5% crystal violet solution (Sigma-Aldrich), and washed extensively under tap water.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.